|
ABCL
|
AbCellera Biologics Inc.
|
US
|
NASDAQ
|
|
AMPH
|
Amphastar Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
AMYT
|
Amryt Pharma plc
|
US
|
NASDAQ
|
|
ANIP
|
ANI Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
ARCT
|
Arcturus Therapeutics Ltd.
|
US
|
NASDAQ
|
|
BBC
|
Virtus LifeSci Biotech Clinical Trials ETF
|
US
|
AMEX
|
|
BLRX
|
BioLineRx Ltd.
|
US
|
NASDAQ
|
|
BMRA
|
Biomerica, Inc.
|
US
|
NASDAQ
|
|
CERT
|
Certara, Inc.
|
US
|
NASDAQ
|
|
CPHI
|
China Pharma Holdings, Inc.
|
US
|
AMEX
|
|
CTLT
|
Catalent, Inc.
|
US
|
NYSE
|
|
CYCN
|
Cyclerion Therapeutics, Inc.
|
US
|
NASDAQ
|
|
EQRX
|
EQRx, Inc.
|
US
|
NASDAQ
|
|
HBIO
|
Harvard Bioscience, Inc.
|
US
|
NASDAQ
|
|
ICLR
|
ICON plc
|
US
|
NASDAQ
|
|
INM
|
InMed Pharmaceuticals Inc.
|
US
|
NASDAQ
|
|
JNJ
|
Johnson & Johnson
|
US
|
NYSE
|
|
KNSA
|
Kiniksa Pharmaceuticals, Ltd.
|
US
|
NASDAQ
|
|
MLAB
|
Mesa Laboratories, Inc.
|
US
|
NASDAQ
|
|
NKTR
|
Nektar Therapeutics
|
US
|
NASDAQ
|